Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease

Scandinavian Journal of Immunology

Volumn 45, Issue 3, 1997, Pages 294-300

  Price, K S ^a   Nestel, F P ^a   Lapp, W S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031043264     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-404.x     Document Type: Article

References (33)

1. Lapp WS, Ghayur T, Mendes M, Seddick M, Seemayer TA. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev 1985;88:107-33.
2. Mowat AMcI, Ferguson A. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology 1982;83:417-23.
3. Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered releases of tumor necrosis factor α during graft-versus-host disease. J Exp Med 1992;175:405-13.
4. Jones JW, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971;45:577-87.
5. Heit H, Wilson R, Fliedner TM, Kohhne E. Mortality of secondary disease in antibiotic treated mouse radiation chimeras. In: Heneghan JB, ed. Germfree Research: Biological Effect of Gnotobiotic Environments. New York: New York Academic Press, 1973:477-83.
6. Van Bekkum DW, Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977;58:787-9.
7. Moore RH, Lampert IA, Chia Y, Aber VR, Cohen J. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice. Transplantation 1987;44:249-53.
8. Deitch EA, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 1987;122:185-9.
9. Gans H, Matsumoto K. The escape of endotoxin from the intestine. Surg Gynec Obstet 1974;139:395-402.
10. Schumann RR, Leong SR, Flaggs GW et al. Structure and function of LPS binding protein. Science 1990;249:1429-33.
11. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;241:1431-3.
12. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharides in rabbits. J Immunol 1979;123:2133-43.
13. Freudenberg MA, Freudenberg N, Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Path 1982;63:56-65.
14. Wright SD, Jong MTC. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med 1986;164:1876-88.
15. Flegel WA, Wolpl A, Mannel DN, Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 1989;57:2237-45.
16. Pace JL, Russell SW, Torres BA, Johnson HM, Gray PW. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 1983;130:2011-2.
17. d, (endotoxin resistance) phenotype. J Exp Med 1986;164:1791-6.
18. Stuehr DJ, Marietta MA. Mammalian nitrate biosynthesis. Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci 1985;82:7738-42.
19. Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-4.
20. Cunningham AJ, Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 1968;14:599-600.
21. Simonsen M. The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Scand 1957;40:480-5.
22. Nolan JP. Intestinal endotoxins as mediators of hepatic injury - an idea whose time has come again. Hepatology 1989;10:887-91.
23. Walker RI. The contribution of intestinal endotoxin to mortality in hosts with compromised resistance: a review. Exp Hemat 1978;6:172-84.
24. Garside P, Hutton AK, Severn A, Liew FY, Mowat McI. Nitric oxide mediates intestinal pathology in graft-versus-host disease. Eur J Immunol 1992;22:2141-5.
25. Cuevas P, Fine J. Production of fatal endotoxic shock by vasoactive substances. Gastroenterology 1973;64:285-91.
26. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CRH. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991;352:342-4.
27. Fomsgaard A, Freudenberg MA, Bendtzen K, Galanos C. Quantitation and biological activities of native tumour necrosis factor from LPS-stimulated human monocytes. APMIS 1990;98:529-34.
28. Nestel F, Kichian K, You-Ten K et al. The role of endotoxin in the pathogenesis of acute graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff S, eds. Graft-Versus-Host Disease, 2nd edn. New York: Marcel Dekker, 1997.
29. Shalaby MR, Fendly B, Sheehan KC, Schreiber D, Ammann AJ. Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation 1989;47:1057-67.
30. Prentice RL, Buckner DC, Clift RA et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effects of a protective environment. N Engl J Med 1983;308:302-7.
31. Beelen DW, Haralambie E, Brandt H et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992;80:2668-76.
32. Krikor K, Nestel FP, Kim D, Ponka P, Lapp WS. IL-2p40 Messenger RNA expression in target organs during acute graft-versus-host-disease. J Immunol 1996;157:2851-6.
33. Jackson SK, Parton J, Barnes A, Poynton CH, Fegan C. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation. Eur J Clin Invest 1993;23:540-5.